Every hospital in a low- or middle-income country runs the same hidden bottleneck: patients get lost between diagnosis, referral, and treatment. Not because the medicine is missing, but because the coordination is. That gap — unglamorous, unsexy, and almost never funded by conventional venture capital — is exactly where catalytic capital does its best work.
What catalytic capital actually funds
Catalytic capital is patient, concessionary, and risk-tolerant by design. It exists to reach the opportunities that market-rate capital structurally can’t: early-stage health infrastructure in frontier markets, tools that reduce cost and save lives before they generate a “venture-scale” return, and systems-level fixes that no single hospital can afford to build alone.
Family offices are uniquely positioned to deploy it. Unlike funds bound to a return benchmark and a fixed fund life, a family office can underwrite a decade-long thesis, accept a longer J-curve, and weigh impact alongside — not instead of — financial return. That combination of patient capital and mission alignment is precisely what health-tech in LMIC markets needs.
The problem Navigacare solves
Navigacare is a dual-product SaaS platform built for exactly this bottleneck: patient journey coordination inside LMIC hospitals. It gives care teams a single source of truth as a patient moves from intake to diagnosis to referral to treatment — the handoffs where patients are most often lost, and where the cost of failure is measured in outcomes, not just revenue.
Built and deployed from Nigeria, Navigacare already carries a C/Can accreditation for its role in cancer-care coordination, and is now expanding across hospital networks that face the same fragmentation problem across the continent.
Why this is a catalytic-capital opportunity, not a grant line item
A grant can fund a pilot. It rarely funds the runway a platform needs to go from one hospital to a network, and from one country to a region. That middle stretch — proven concept, pre-scale infrastructure, real but early revenue — is the classic capital gap catalytic investors are built to close. It’s also where a family office’s flexibility on return timeline and structure (debt, equity, or blended) matters more than at any other stage.
What this looks like in practice
- Structure: blended capital — grant-anchored pilots paired with a SAFE or structured equity for scale-up capital
- Time horizon: patient capital, 5–10 years, aligned with health-system change rather than a single fund cycle
- Impact thesis: measurable reduction in patient loss-to-follow-up across hospital networks in LMIC markets
- Financial thesis: SaaS unit economics once the network effect across hospitals takes hold
If your office already thinks about impact investing, health equity, or frontier-market infrastructure as part of its mandate, this is the kind of opportunity that sits at the center of that thesis rather than the edge of it.
Learn more or start a conversation: navigacare.online
Navigacare is a patient journey coordination platform for hospitals in low- and middle-income countries, built and operated by Planetbridge Nigeria Limited and WhiteRock Innovations Ltd.
Leave a Reply